MacroGenics
MGNX
113 hedge funds and large institutions have $549M invested in MacroGenics in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 47 increasing their positions, 26 reducing their positions, and 12 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
81% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 26
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
6.9% more ownership
Funds ownership: 82.58% → 89.48% (+6.9%)
2% more funds holding
Funds holding: 111 → 113 (+2)
2% more capital invested
Capital invested by funds: $537M → $549M (+$11.2M)
33% less call options, than puts
Call options by funds: $510K | Put options by funds: $765K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$40.3M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$19.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.64M |
| 4 |
O
OppenheimerFunds
New York
|
+$4.96M |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$3.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRC
Blue Ridge Capital
New York
|
-$25.3M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$2.97M |
| 3 |
SIM
Spark Investment Management
New York
|
-$2.93M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.84M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.64M |
MGNX Hedge Fund Activity: Q2 2017 in Review
113 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2017, worth a combined $549M — up 2.1% from $537M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new MGNX positions and 12 closed out — a net gain of 2 holders — while 47 added to existing stakes and 26 trimmed.
The largest buyer was Boxer Capital, opening a new position worth an estimated $40.3M. The largest seller was Blue Ridge Capital, exiting entirely with an estimated $25.3M sold.
- 113 institutional investors held MacroGenics (MGNX) as of Q2 2017, up from 111 in Q1 2017.
- Funds reported $549M of MacroGenics stock for Q2 2017, up 2.1% quarter-over-quarter.
- 14 funds opened new MacroGenics positions in Q2 2017 and 12 closed out, a net change of +2 holders.
- The largest MacroGenics buyer in Q2 2017 was Boxer Capital, an estimated $40.3M added.
- The largest MacroGenics seller in Q2 2017 was Blue Ridge Capital, an estimated $25.3M sold.
Based on aggregated 13F filings for Q2 2017.